Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease

S. H. Saverymuttu, Sanjeev Gupta, A. Keshavarzian, B. Donovan, H. J. Hodgson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A short-term double-blind controlled trial has been performed comparing a slow-release 5'-aminosalicylic acid (5-ASA) tablet (Pentasa) with placebo in the outpatient treatment of mild and moderate active Crohn's colitis. The disease activity was measured objectively by quantitation of the faecal excretion of 111In-labelled autologous granulocytes, which directly reflects gut inflammation. Twelve patients were randomized to receive either Pentasa or placebo. After 10 days of treatment faecal granulocyte excretion fell in all patients receiving 5-ASA, while no consistent change was found in the placebo group. These results suggest that this slow-release preparation of 5-ASA should be tested in larger controlled therapeutic trials over a longer period of time.

Original languageEnglish (US)
Pages (from-to)89-91
Number of pages3
JournalDigestion
Volume33
Issue number2
StatePublished - 1986
Externally publishedYes

Fingerprint

Mesalamine
Crohn Disease
Placebos
Granulocytes
Colitis
Tablets
Outpatients
Therapeutics
Inflammation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Saverymuttu, S. H., Gupta, S., Keshavarzian, A., Donovan, B., & Hodgson, H. J. (1986). Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease. Digestion, 33(2), 89-91.

Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease. / Saverymuttu, S. H.; Gupta, Sanjeev; Keshavarzian, A.; Donovan, B.; Hodgson, H. J.

In: Digestion, Vol. 33, No. 2, 1986, p. 89-91.

Research output: Contribution to journalArticle

Saverymuttu, SH, Gupta, S, Keshavarzian, A, Donovan, B & Hodgson, HJ 1986, 'Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease', Digestion, vol. 33, no. 2, pp. 89-91.
Saverymuttu, S. H. ; Gupta, Sanjeev ; Keshavarzian, A. ; Donovan, B. ; Hodgson, H. J. / Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease. In: Digestion. 1986 ; Vol. 33, No. 2. pp. 89-91.
@article{39583ddc88ec45d49c3e48181b185aec,
title = "Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease",
abstract = "A short-term double-blind controlled trial has been performed comparing a slow-release 5'-aminosalicylic acid (5-ASA) tablet (Pentasa) with placebo in the outpatient treatment of mild and moderate active Crohn's colitis. The disease activity was measured objectively by quantitation of the faecal excretion of 111In-labelled autologous granulocytes, which directly reflects gut inflammation. Twelve patients were randomized to receive either Pentasa or placebo. After 10 days of treatment faecal granulocyte excretion fell in all patients receiving 5-ASA, while no consistent change was found in the placebo group. These results suggest that this slow-release preparation of 5-ASA should be tested in larger controlled therapeutic trials over a longer period of time.",
author = "Saverymuttu, {S. H.} and Sanjeev Gupta and A. Keshavarzian and B. Donovan and Hodgson, {H. J.}",
year = "1986",
language = "English (US)",
volume = "33",
pages = "89--91",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Effect of a slow-release 5'-aminosalicylic acid preparation on disease activity in Crohn's disease

AU - Saverymuttu, S. H.

AU - Gupta, Sanjeev

AU - Keshavarzian, A.

AU - Donovan, B.

AU - Hodgson, H. J.

PY - 1986

Y1 - 1986

N2 - A short-term double-blind controlled trial has been performed comparing a slow-release 5'-aminosalicylic acid (5-ASA) tablet (Pentasa) with placebo in the outpatient treatment of mild and moderate active Crohn's colitis. The disease activity was measured objectively by quantitation of the faecal excretion of 111In-labelled autologous granulocytes, which directly reflects gut inflammation. Twelve patients were randomized to receive either Pentasa or placebo. After 10 days of treatment faecal granulocyte excretion fell in all patients receiving 5-ASA, while no consistent change was found in the placebo group. These results suggest that this slow-release preparation of 5-ASA should be tested in larger controlled therapeutic trials over a longer period of time.

AB - A short-term double-blind controlled trial has been performed comparing a slow-release 5'-aminosalicylic acid (5-ASA) tablet (Pentasa) with placebo in the outpatient treatment of mild and moderate active Crohn's colitis. The disease activity was measured objectively by quantitation of the faecal excretion of 111In-labelled autologous granulocytes, which directly reflects gut inflammation. Twelve patients were randomized to receive either Pentasa or placebo. After 10 days of treatment faecal granulocyte excretion fell in all patients receiving 5-ASA, while no consistent change was found in the placebo group. These results suggest that this slow-release preparation of 5-ASA should be tested in larger controlled therapeutic trials over a longer period of time.

UR - http://www.scopus.com/inward/record.url?scp=0022643402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022643402&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 89

EP - 91

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 2

ER -